DAXOR

Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100™ (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for use in a broad range of medical and surgical conditions. Our mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Our vision is optimal blood volume for all. Daxor is proud to be a Principal Member and Value Initiative Industry Alliance Partner with the SNMMI. We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for use in a broad range of medical and surgical conditions. Watch Daxor CEO, Michael Feldschuh, Discuss How BVA-100 Technology is Joining to Fight COVID-19. As the pioneer in blood volume analysis, Daxor provides education and the resources needed to ensure easy onboarding along with continuing support to drive maximum value from your BVA system throughout your facility.